3rd Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

Firm
Client
Income
—
Expenses
$79,149
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocacy for Reauthorization of Pandemic All-Hazards Preparedness Act (PAHPA) in House (HR 2405) and Senate (S.1855). Advocacy for House and Senate Labor-HHS Appropriations funding allocation in FY-2013 and FY-2014 for the Biodefense Advanced Research and Development Authority (BARDA) at HHS. Education of Members of Congress and Staff on recombinant protective antigen (rPA) anthrax vaccine.

LobbyistCovered position, as disclosed
FRANCESCA COOK Sr. V.P. Policy and Government Affairs
MARK EDWARD COOKE Sr Director Government Affairs

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1855 (112th), H.R. 2405 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.